Active Ingredient: DARIFENACIN HYDROBROMIDE
Proprietary Name: DARIFENACIN HYDROBROMIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 7.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A209571
Product Number: 002
Approval Date: Oct 22, 2019
Applicant Holder Full Name: XIROMED PHARMA ESPANA SL
Marketing Status:
Discontinued
Patent and Exclusivity Information
